Friday 6 November 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue: +10.9%
EPS: −351.9%
Free cash flow: −11.5%
Total debt: +3.28%

Quarter to September 2026, against a year earlier

171.43 2.95 +1.75%

Follow RGEN

Alert me

Market cap: $10.8B
P/E: 0.0×
Fwd P/E: −615×
Dividend yield: —
F-score: 6/9
Altman Z: 7.49
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Repligen Corporation (RGEN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Repligen Corporation (RGEN) trades at a P/B ratio of 4.6×. Over the past ten years it has ranged from 2.0× (February 2018) to 12.3× (June 2015); the current reading is higher than 39% of that period. That is above the Medical Instruments & Supplies industry median of 2.3× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RGEN/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Repligen Corporation P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RGEN/metrics/pb-ratio">Repligen Corporation (RGEN) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	4.4×	7.19%
FY2024	4.1×	(19.73%)
FY2023	5.1×	8.13%
FY2022	4.7×	(43.52%)
FY2021	8.3×	26.41%
FY2020	6.6×	56.08%
FY2019	4.2×	12.53%
FY2018	3.7×	56.55%
FY2017	2.4×	(61.35%)
FY2016	6.2×	(18.23%)

Period	P/B ratio	Change
Sep 2026	5.2×	42.61%
Jun 2026	3.6×	15.58%
Mar 2026	3.2×	(27.92%)
Dec 2025	4.4×	21.18%
43 more quarters	Free account

Against its own ten years

Low 2.0× High 12.3×

Ten-year median 5.0×

Current reading's percentile 42

Company	P/B ratio
BLCO Bausch + Lomb Corporation compare	1.1×
COO The Cooper Companies, Inc. compare	1.5×
AVTR Avantor, Inc. compare	1.8×
BAX Baxter International Inc. compare	2.0×
TFX Teleflex Incorporated compare	2.3×
ALGN Align Technology, Inc. compare	2.7×
SOLV Solventum Corporation compare	3.1×
ATR AptarGroup, Inc. compare	3.5×
RGEN Repligen Corporation	4.6×
Medical Instruments & Supplies industry median	2.3×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Repligen Corporation (RGEN) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on RGEN

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on RGEN

Stockrow Weekly